FDA Inspection 1027344 — Dong Sung Bio Pharm Co., Ltd.
The FDA completed an inspection of Dong Sung Bio Pharm Co., Ltd. on September 8, 2017 in Dobong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 8, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dobong (Korea (the Republic of))